Winston Medical Supply CoROCO:6817 -1.82%85 ROE % is 25.26% as of Dec. 2025, which is 17% below its 10-year median of 30.27. GuruFocus rates ROCO:6817 with a GF Score™ of 85/100 and a GF Value™ of NT$102.58 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 934 Drug Manufacturers companies, Winston Medical Supply Co ranks better than 93.36% on this metric.
The historical rank and industry rank for Winston Medical Supply Co's ROE % or its related term are showing as below:
ROCO:6817'
s ROE % Range Over the Past 10 Years
Min: -13.4 Med: 30.27 Max: 43.69
Current: 28.29
During the past 9 years, Winston Medical Supply Co's highest ROE % was 43.69%. The lowest was -13.40%. And the median was 30.27%.
ROCO:6817's ROE % is ranked better than 93.36% of 934
companies
in the Drug Manufacturers industry
Industry Median: 6.02
vs ROCO:6817: 28.29
Winston Medical Supply Co (ROCO:6817) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Winston Medical Supply Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Winston Medical Supply Co ROE % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Winston Medical Supply Co's ROE % distribution charts can be found below:
* The bar in red indicates where Winston Medical Supply Co's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Winston Medical Supply Co (ROCO:6817) has a ROE % of 25.26% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Winston Medical Supply Co and its competitors. This is 17% below median its historical median of 30.27. According to the industry distribution chart, Winston Medical Supply Co ranks #62 out of 934 companies in the Drug Manufacturers industry, placing it in the top 6.6%.
Is Winston Medical Supply Co's ROE % too high?
Winston Medical Supply Co's current ROE % of 25.26% is 17% below median its 10-year median of 30.27. The Drug Manufacturers industry median ROE % is 6.02. Winston Medical Supply Co's value of 25.26% is 319.6% above this industry median. Based on the distribution chart, Winston Medical Supply Co ranks #62 out of 934 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Winston Medical Supply Co has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Winston Medical Supply Co's ROE % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Winston Medical Supply Co ranks #62 out of 934 companies for ROE %. This places Winston Medical Supply Co in the top 7% of its industry — outperforming the majority of peers. The industry median ROE % is 6.02. Winston Medical Supply Co's value of 25.26% is 319.6% above this benchmark. While the company's 10-year median is 30.27 vs. the industry median of 6.02, Winston Medical Supply Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Drug Manufacturers company?
The median ROE % among Drug Manufacturers companies is 6.02, based on 934 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Winston Medical Supply Co's current ROE % of 25.26% is 319.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Winston Medical Supply Co and its competitors. For the Drug Manufacturers industry, the median ROE % is 6.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Winston Medical Supply Co's current ROE % is 25.26%, which is 17% below median its own 10-year median of 30.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Winston Medical Supply Co stock overvalued right now?
Based on GuruFocus' analysis, Winston Medical Supply Co (ROCO:6817) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$102.58, compared to a current price of NT$59.20 — trading 42.3% below its estimated fair value. The current ROE % is 25.26%, which is 17% below median its 10-year median of 30.27 and 319.6% above the Drug Manufacturers industry median of 6.02. Winston Medical Supply Co's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Winston Medical Supply Co (ROCO:6817), the current ROE % is 25.26% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Winston Medical Supply Co (ROCO:6817) Overvalued in 2026?
Based on GuruFocus' analysis, Winston Medical Supply Co stock appears to be undervalued.
The current stock price of NT$59.20 is trading 42.3% below its estimated GF Value™ of NT$102.58.
GuruFocus considers Winston Medical Supply Co to be Significantly Undervalued.
Key valuation signals for ROCO:6817:
ROE %: 25.26% (17% below median its 10-year median of 30.27)
GF Value™: NT$102.58 vs. price of NT$59.20 (42.3% below fair value)
Industry Position: 319.6% above the Drug Manufacturers median (#62 of 934)
No single metric tells the full story. See the ROCO:6817 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Winston Medical Supply Co Ltd is a manufacturer of medical products. It produces sterile ophthalmic preparations, hormone preparations and healthy products.
85GF Score
Get the complete analysis for ROCO:6817
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6817 has been successfully added to your 
